669
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Prevalence and Genotype Distribution of Human Papillomavirus in 92,932 Cases in Shanghai, China

, , , & ORCID Icon
Pages 517-526 | Received 01 Oct 2022, Accepted 07 Jun 2023, Published online: 16 Jun 2023

References

  • Ntanasis-Stathopoulos I , KyriazoglouA , LiontosM , DimopoulosMA , GavriatopoulouM. Current trends in the management and prevention of human papillomavirus (HPV) infection. J. BUON25(3), 1281–1285 (2020).
  • Zur Hausen H , GissmannL , SteinerW , DippoldW , DregerI. Human papilloma viruses and cancer. Bibl. Haematol. (43), 569–571 (1975).
  • Bosch FX , DurstM , SchwarzE , BoukampP , FusenigNE , ZurHausen H. The early genes E6 and E7 of cancer associated human papilloma viruses as targets of tumor suppression?Behring Inst. Mitt. (89), 108–121 (1991).
  • Dust K , CarpenterM , ChenJCet al. Human papillomavirus 16 E6 and E7 oncoproteins alter the abundance of proteins associated with DNA damage response, immune signaling and epidermal differentiation. Viruses14(8), (2022).
  • Durst M , GissmannL , IkenbergH , ZurHausen H. A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc. Natl Acad. Sci. USA80(12), 3812–3815 (1983).
  • Vieira GV , SomeraDos Santos F , LepiqueAPet al. Proteases and HPV-induced carcinogenesis. Cancers (Basel)14(13), (2022).
  • Bhattacharjee R , DasSS , BiswalSSet al. Mechanistic role of HPV-associated early proteins in cervical cancer: Molecular pathways and targeted therapeutic strategies. Crit. Rev. Oncol. Hematol.174, 103675 (2022).
  • Chelimo C , WouldesTA , CameronLD , ElwoodJM. Risk factors for and prevention of human papillomaviruses (HPV), genital warts and cervical cancer. J. Infect66(3), 207–217 (2013).
  • Berman TA , SchillerJT. Human papillomavirus in cervical cancer and oropharyngeal cancer: one cause, two diseases. Cancer123(12), 2219–2229 (2017).
  • Sofiani VH , VeisiP , RukerdMRZ , GhaziR , NakhaieM. The complexity of human papilloma virus in cancers: a narrative review. Infect Agent Cancer18(1), 13 (2023).
  • Petca A , BorislavschiA , ZvancaME , PetcaRC , SandruF , DumitrascuMC. Non-sexual HPV transmission and role of vaccination for a better future (review). Exp. Ther. Med.20(6), 186 (2020).
  • Gallay C , MirandaE , SchaeferSet al. Human papillomavirus (HPV) contamination of gynaecological equipment. Sex Transm. Infect92(1), 19–23 (2016).
  • Mammas IN , DalianisT , DoukasSGet al. Paediatric virology and human papillomaviruses: an update. Exp. Ther. Med.17(6), 4337–4343 (2019).
  • Zhao D , ZhangL , XieFet al. Outcomes of prior cervical cytology and HR-HPV testing in women subsequently diagnosed with CIN1, CIN2/3, and invasive cervical cancer: a 4-year routine clinical experience after implementation of systematic training and quality control programs. BMC Cancer20(1), 810 (2020).
  • Branca M , CiottiM , GiorgiCet al. Up-regulation of proliferating cell nuclear antigen (PCNA) is closely associated with high-risk human papillomavirus (HPV) and progression of cervical intraepithelial neoplasia (CIN), but does not predict disease outcome in cervical cancer. Eur. J. Obstet. Gynecol. Reprod. Biol.130(2), 223–231 (2007).
  • Arbyn M , TommasinoM , DepuydtC , DillnerJ. Are 20 human papillomavirus types causing cervical cancer?J. Pathol.234(4), 431–435 (2014).
  • Spence T , BruceJ , YipKW , LiuFF. HPV associated head and neck cancer. Cancers (Basel)8(8), (2016).
  • Melo BaC , VilarLG , OliveiraNRet al. Human papillomavirus infection and oral squamous cell carcinoma – a systematic review. Braz. J. Otorhinolaryngol.87(3), 346–352 (2021).
  • Sun JX , XuJZ , LiuCQet al. The association between human papillomavirus and bladder cancer: evidence from meta-analysis and two-sample mendelian randomization. J. Med. Virol.95(1), e28208 (2023).
  • Gupta R , RadyPL , DoanHQ , TyringSK. Development of a beta-HPV vaccine: Updates on an emerging frontier of skin cancer prevention. J. Clin. Virol.126, 104348 (2020).
  • Anic GM , GiulianoAR. Genital HPV infection and related lesions in men. Prev. Med.53(Suppl. 1), S36–S41 (2011).
  • Liu M , HeZ , ZhangCet al. Prevalence, incidence, clearance, and associated factors of genital human papillomavirus infection among men: a population-based cohort study in rural China. Cancer Epidemiol. Biomarkers Prev.23(12), 2857–2865 (2014).
  • Vives A , CosentinoM , PalouJ. The role of human papilloma virus test in men: First exhaustive review of literature. Actas Urol. Esp. (Engl. Ed.)44(2), 86–93 (2020).
  • Li N , FranceschiS , Howell-JonesR , SnijdersPJ , CliffordGM. Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: variation by geographical region, histological type and year of publication. Int. J. Cancer128(4), 927–935 (2011).
  • Zhu X , WangY , LvZ , SuJ. Prevalence and genotype distribution of high-risk HPV infection among women in Beijing, China. J. Med. Virol.93(8), 5103–5109 (2021).
  • Tang SY , LiaoYQ , HuY , ShenHY , WanYP , WuYM. HPV prevalence and genotype distribution among women from Hengyang District of Hunan Province, China. Front Public Health9, 710209 (2021).
  • Zhang YY , XuXQ , ZhangD , WuJ , ZhangHX. Triage human papillomavirus testing for cytology-based cervical screening in women of different ages in primary hospitals: A retrospective clinical study. Medicine (Baltimore)99(38), e22320 (2020).
  • Li Y , LiuX , HanC , RenC. Prevalence and genotype distribution of high-risk human papillomavirus in 34 420 cases in Yangzhou city, Jiangsu province, China. J. Med. Virol.93(8), 5095–5102 (2021).
  • Yan L , YangJ , LongX , ZhouD. Epidemiological Characteristics of human papillomavirus (HPV) infection in different groups of women in Chongqing, China. Jpn. J. Infect Dis.74(4), 369–372 (2021).
  • Dunne EF , ParkIU. HPV and HPV-associated diseases. Infect Dis. Clin. North Am.27(4), 765–778 (2013).
  • Yang J , WangW , WangZet al. Prevalence, genotype distribution and risk factors of cervical HPV infection in Yangqu, China: a population-based survey of 10086 women. Hum. Vaccin. Immunother.16(7), 1645–1652 (2020).
  • Liu J , MaS , QinCet al. Prevalence and genotype distribution of human papillomavirus in Zhengzhou, China, in 2016. Arch. Virol.165(3), 731–736 (2020).
  • Wang J , TangD , WangKet al. HPV genotype prevalence and distribution during 2009–2018 in Xinjiang, China: baseline surveys prior to mass HPV vaccination. BMC Womens Health19(1), 90 (2019).
  • Yan X , ShenL , XiaoY , WangQ , LiF , QianY. Prevalence, characteristics, and distribution of HPV genotypes in women from Zhejiang Province, 2016-2020. Virol. J.18(1), 208 (2021).
  • Wang L , YuC , NiXet al. Prevalence characteristics of human papillomavirus (HPV) infection among women receiving physical examinations in the Shangcheng District, Hangzhou city, China. Sci. Rep.11(1), 16538 (2021).
  • Jiang L , TianX , PengDet al. HPV prevalence and genotype distribution among women in Shandong Province, China: analysis of 94,489 HPV genotyping results from Shandong’s largest independent pathology laboratory. PLOS ONE14(1), e0210311 (2019).
  • Chen Z , WangQ , DingX , LiQ , ZhongR , RenH. Characteristics of HPV prevalence in Sichuan Province, China. Int. J. Gynaecol. Obstet131(3), 277–280 (2015).
  • Luo LP , HeP , LiuQTet al. Prevalence and genotype distribution of HPV infection among 214,715 women from Southern China, 2012–2018: baseline measures prior to mass HPV vaccination. BMC Infect Dis.21(1), 328 (2021).
  • Tang Y , ZhengL , YangS , LiB , SuH , ZhangLP. Epidemiology and genotype distribution of human papillomavirus (HPV) in Southwest China: a cross-sectional five years study in non-vaccinated women. Virol. J.14(1), 84 (2017).
  • Zhang C , ZhangC , HuangJ , WuZ , MeiX , ShiW. Prevalence and genotype distribution of human papillomavirus among females in the suburb of Shanghai, China. J. Med. Virol.90(1), 157–164 (2018).
  • Li H , LiP , HuangL , SunL , RenH , LiP. Prevalence characteristics of cervical human papillomavirus (HPV) infection in the Zhoupu District, Shanghai City, China. Virol. J.17(1), 84 (2020).
  • Li Z , LiuF , ChengSet al. Prevalence of HPV infection among 28,457 Chinese women in Yunnan Province, southwest China. Sci. Rep.6, 21039 (2016).
  • Zhu Y , QianF , ZouWet al. Prevalence and genotype distribution of human papillomavirus infection in Huzhou City, eastern China, 2018-2019. Trans R. Soc. Trop. Med. Hyg.115(1), 30–37 (2021).
  • Li M , DuX , LuMet al. Prevalence characteristics of single and multiple HPV infections in women with cervical cancer and precancerous lesions in Beijing, China. J. Med. Virol.91(3), 473–481 (2019).
  • Han X , SongG , LiYet al. Prevalence and genotype distribution of human papillomavirus infection among women aged 30–65 years in Xi’an, China: a population-based study of 14,655 women. Hum. Vaccin. Immunother.17(12), 5439–5446 (2021).
  • Jin R , QianH , ZhangYet al. The prevalence and genotype distribution of human papillomaviruses among women in Taizhou, China. Medicine (Baltimore)98(39), e17293 (2019).
  • Kim MJ , KimJJ , KimS. Type-specific prevalence of high-risk human papillomavirus by cervical cytology and age: data from the health check-ups of 7,014 Korean women. Obstet. Gynecol. Sci.56(2), 110–120 (2013).
  • Wang S , WeiH , WangNet al. The prevalence and role of human papillomavirus genotypes in primary cervical screening in the northeast of China. BMC Cancer12, 160 (2012).
  • Owosho AA , WileyR , StansburyT , GbadamosiSO , RyderJS. Trends in human papillomavirus-related oropharyngeal squamous cell carcinoma incidence, Vermont 1999–2013. J. Comm. Health43(4), 731–737 (2018).